People on the Move Archives - Page 69 of 126

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

THIS WEEK'S STORIES

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

FDA Grants Breakthrough Device Status to Prevencio’s AI-Powered Blood Test for Coronary Artery Disease

May 13, 2025

Redwire Chief Scientist Dr. Kenneth Savin Named to TIME100 Health List for Pioneering Space-Based Biotech Research

May 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

Ted Myles Named CEO of Cellarity as Company Prepares for First Clinical Trial

Adtalem Appoints Megan Noel as Chief Corporate Affairs Officer

Aera Therapeutics Names Paul Conrad as Chief Business and Financial Officer

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Most Read

K Health’s AI Physician Mode Joins Mayo Clinic Platform to Boost Primary Care Efficiency

FDA Approves GE HealthCare’s Optison for Pediatric Use, Expanding Access to Enhanced Heart Imaging

Vicarious Surgical Partners with UMass Memorial Medical Center to Advance Robotic Surgery Integration

Freespira Gains FDA Clearance for At-Home Anxiety and PTSD Treatment for Adolescents

EDITOR PICKS

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

THIS WEEK'S STORIES

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

FDA Grants Breakthrough Device Status to Prevencio’s AI-Powered Blood Test for Coronary Artery Disease

Redwire Chief Scientist Dr. Kenneth Savin Named to TIME100 Health List for Pioneering Space-Based Biotech Research

POPULAR CATEGORY

ABOUT US

FOLLOW US